Huaxia Financial Statements From 2010 to 2024

301267 Stock   20.18  0.81  3.86%   
Huaxia Eye financial statements provide useful quarterly and yearly information to potential Huaxia Eye Hospital investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Huaxia Eye financial statements helps investors assess Huaxia Eye's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Huaxia Eye's valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
0.1294
Market Capitalization
20 B
Enterprise Value Revenue
3.6216
Revenue
4.1 B
Huaxia Eye Hospital does not presently have any fundamental trends for analysis.
Check Huaxia Eye financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Huaxia Eye's main balance sheet or income statement drivers, such as , as well as many indicators such as . Huaxia financial statements analysis is a perfect complement when working with Huaxia Eye Valuation or Volatility modules.
  
This module can also supplement various Huaxia Eye Technical models . Check out the analysis of Huaxia Eye Correlation against competitors.

Huaxia Eye Hospital Company Current Valuation Analysis

Huaxia Eye's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Huaxia Eye Current Valuation

    
  14.82 B  
Most of Huaxia Eye's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Huaxia Eye Hospital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Huaxia Eye Hospital has a Current Valuation of 14.82 B. This is 3.18% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 10.85% higher than that of the company.

Huaxia Eye Hospital Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Huaxia Eye's current stock value. Our valuation model uses many indicators to compare Huaxia Eye value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Huaxia Eye competition to find correlations between indicators driving Huaxia Eye's intrinsic value. More Info.
Huaxia Eye Hospital is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.59  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Huaxia Eye Hospital is roughly  1.68 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Huaxia Eye by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Huaxia Eye's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Huaxia Eye Financial Statements

Huaxia Eye stakeholders use historical fundamental indicators, such as Huaxia Eye's revenue or net income, to determine how well the company is positioned to perform in the future. Although Huaxia Eye investors may analyze each financial statement separately, they are all interrelated. For example, changes in Huaxia Eye's assets and liabilities are reflected in the revenues and expenses on Huaxia Eye's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Huaxia Eye Hospital. Please read more on our technical analysis and fundamental analysis pages.
Huaxia Eye is entity of China. It is traded as Stock on SHE exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Huaxia Stock

Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.